Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Dec 2025 is 4.16%
Standalone Net Profit
YoY Growth in quarter ended Dec 2025 is 333.33%
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Dec 2025 is 14.51%
Interest
YoY Growth in quarter ended Dec 2025 is 138.35%
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Dec 2025 has improved from Dec 2024
Compare Quarterly Results Of Beta Drugs Ltd With
Quarterly - Net Sales
QoQ Growth in quarter ended Dec 2025 is -7.71% vs 12.87% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 4.16%
Quarterly - Standalone Net Profit
QoQ Growth in quarter ended Dec 2025 is 115.23% vs 101.33% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 333.33%
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Dec 2025 is 38.48% vs -17.31% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 14.51%
Quarterly - Interest
QoQ Growth in quarter ended Dec 2025 is 6.73% vs 123.31% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 138.35%
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025
YoY Growth in quarter ended Dec 2025 has improved from Dec 2024






